Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Hoth Therapeutics Inc
HOTH
Healthcare
Biotechnology
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It develops HT-001, a topical formulation in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell...
derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for the treatment and/or prevention of Alzheimer’s or other neuroinflammatory diseases; and HT-004 for treatment of asthma and allergies using inhalational administration. The company is developing BioLexa Platform, a proprietary, patented, drug compound platform in Phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; Isoprene Pharmaceuticals, Inc.; the North Carolina State Universi...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:HOTH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(548)
•••
Iseneschal
X
Comment by
Iseneschal
on Mar 19, 2024 10:59am
RE:HOTH.....Oh boy...heres the big bidder
Big Bids sink ships.... I always say ; )
(548)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 19, 2024 10:55am
HOTH.....Oh boy...heres the big bidder
That is the kiss o death Hurry up and dye
(548)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 19, 2024 10:46am
HOTH...might just be done for the day ; )
No position
(548)
•••
Iseneschal
X
Comment by
Iseneschal
on Mar 19, 2024 9:40am
RE:HOTH....LFG !!!!!
Sold all on stop .......grrrr Flat trade
(548)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 19, 2024 9:35am
HOTH....LFG !!!!!
$1.50 now
(548)
•••
Iseneschal
X
Comment by
Iseneschal
on Mar 19, 2024 9:21am
RE:Hoth ...early a.m runner on NR $1.75
Bigger add to starting position at $1.41 Cheers !
(548)
•••
Iseneschal
X
Comment by
Iseneschal
on Mar 19, 2024 8:29am
RE:Hoth ...early a.m runner on NR $1.75
Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ 2024-03-19 05:21 ET - News Release NEW YORK March 19, 2024
...more
(548)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 19, 2024 8:25am
Hoth ...early a.m runner on NR $1.75
I'm in small
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 13, 2024 11:45am
New Press Release - Hoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024
NEW YORK, Feb. 13, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Robb Knie, Chief Executive Officer, is scheduled to attend the BIO CEO and Investor Conference in New York, NY. To learn more about BIO CEO and Investor Conference...
read article.
(856)
•••
7Twiggy
X
Post by
7Twiggy
on Jan 18, 2024 2:11pm
Makes me wonder
The way I understand the news release, this is the second approval for another group of patients with more serious conditions than the first. You think there must be something positive going on
...more
(856)
•••
7Twiggy
X
Post by
7Twiggy
on Jan 18, 2024 12:49pm
One third of the float traded
You must be talking about a different stock. This one has a 4.5 million float and has traded 1.5 million shares or about one third of the shares out. That is one heck of a lot of volume
...more
(548)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 18, 2024 10:39am
HOTH....sold
Vols aren't good enough Thanks for the Lunch money
(548)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 18, 2024 10:34am
HOTH....moving up slowly ...she got....
Wonky eyeball Gonna be good....on watch with a nice position
(548)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 18, 2024 8:34am
HOTH.....NR this a.m....LFG!
Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients 2024-01-18 05:20 PT - News Release Patients will
...more
(856)
•••
7Twiggy
X
Post by
7Twiggy
on Dec 21, 2023 11:35am
Tax loss selling
Lots of risks, but also lots of potential. Added a little more. Hoping for the home run.
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Team Spotlight: Every discovery begins with the people behind it
Podcasts